287 related articles for article (PubMed ID: 28826672)
1. Delta-Secretase Phosphorylation by SRPK2 Enhances Its Enzymatic Activity, Provoking Pathogenesis in Alzheimer's Disease.
Wang ZH; Liu P; Liu X; Manfredsson FP; Sandoval IM; Yu SP; Wang JZ; Ye K
Mol Cell; 2017 Sep; 67(5):812-825.e5. PubMed ID: 28826672
[TBL] [Abstract][Full Text] [Related]
2. Spatiotemporal activation of the C/EBPβ/δ-secretase axis regulates the pathogenesis of Alzheimer's disease.
Wang H; Liu X; Chen S; Ye K
Proc Natl Acad Sci U S A; 2018 Dec; 115(52):E12427-E12434. PubMed ID: 30530690
[TBL] [Abstract][Full Text] [Related]
3. Delta-secretase (AEP) mediates tau-splicing imbalance and accelerates cognitive decline in tauopathies.
Wang ZH; Liu P; Liu X; Yu SP; Wang JZ; Ye K
J Exp Med; 2018 Dec; 215(12):3038-3056. PubMed ID: 30373880
[TBL] [Abstract][Full Text] [Related]
4. C/EBPβ regulates delta-secretase expression and mediates pathogenesis in mouse models of Alzheimer's disease.
Wang ZH; Gong K; Liu X; Zhang Z; Sun X; Wei ZZ; Yu SP; Manfredsson FP; Sandoval IM; Johnson PF; Jia J; Wang JZ; Ye K
Nat Commun; 2018 May; 9(1):1784. PubMed ID: 29725016
[TBL] [Abstract][Full Text] [Related]
5. Traumatic brain injury triggers APP and Tau cleavage by delta-secretase, mediating Alzheimer's disease pathology.
Wu Z; Wang ZH; Liu X; Zhang Z; Gu X; Yu SP; Keene CD; Cheng L; Ye K
Prog Neurobiol; 2020 Feb; 185():101730. PubMed ID: 31778772
[TBL] [Abstract][Full Text] [Related]
6. SRPK2 phosphorylates tau and mediates the cognitive defects in Alzheimer's disease.
Hong Y; Chan CB; Kwon IS; Li X; Song M; Lee HP; Liu X; Sompol P; Jin P; Lee HG; Yu SP; Ye K
J Neurosci; 2012 Nov; 32(48):17262-72. PubMed ID: 23197718
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Early Growth Response 1 in the Hippocampus Alleviates Neuropathology and Improves Cognition in an Alzheimer Model with Plaques and Tangles.
Qin X; Wang Y; Paudel HK
Am J Pathol; 2017 Aug; 187(8):1828-1847. PubMed ID: 28641077
[TBL] [Abstract][Full Text] [Related]
8. δ-Secretase-cleaved Tau stimulates Aβ production via upregulating STAT1-BACE1 signaling in Alzheimer's disease.
Zhang Z; Li XG; Wang ZH; Song M; Yu SP; Kang SS; Liu X; Zhang Z; Xie M; Liu GP; Wang JZ; Ye K
Mol Psychiatry; 2021 Feb; 26(2):586-603. PubMed ID: 30382187
[TBL] [Abstract][Full Text] [Related]
9. Delta-secretase cleaves amyloid precursor protein and regulates the pathogenesis in Alzheimer's disease.
Zhang Z; Song M; Liu X; Su Kang S; Duong DM; Seyfried NT; Cao X; Cheng L; Sun YE; Ping Yu S; Jia J; Levey AI; Ye K
Nat Commun; 2015 Nov; 6():8762. PubMed ID: 26549211
[TBL] [Abstract][Full Text] [Related]
10. Delta-secretase triggers Alzheimer's disease pathologies in wild-type hAPP/hMAPT double transgenic mice.
Wu Z; Liu X; Cheng L; Ye K
Cell Death Dis; 2020 Dec; 11(12):1058. PubMed ID: 33311478
[TBL] [Abstract][Full Text] [Related]
11. Delta-secretase-cleaved Tau antagonizes TrkB neurotrophic signalings, mediating Alzheimer's disease pathologies.
Xiang J; Wang ZH; Ahn EH; Liu X; Yu SP; Manfredsson FP; Sandoval IM; Ju G; Wu S; Ye K
Proc Natl Acad Sci U S A; 2019 Apr; 116(18):9094-9102. PubMed ID: 31004063
[TBL] [Abstract][Full Text] [Related]
12. Amyloid precursor protein reduction enhances the formation of neurofibrillary tangles in a mutant tau transgenic mouse model.
Vanden Dries V; Stygelbout V; Pierrot N; Yilmaz Z; Suain V; De Decker R; Buée L; Octave JN; Brion JP; Leroy K
Neurobiol Aging; 2017 Jul; 55():202-212. PubMed ID: 28464981
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of delta-secretase improves cognitive functions in mouse models of Alzheimer's disease.
Zhang Z; Obianyo O; Dall E; Du Y; Fu H; Liu X; Kang SS; Song M; Yu SP; Cabrele C; Schubert M; Li X; Wang JZ; Brandstetter H; Ye K
Nat Commun; 2017 Mar; 8():14740. PubMed ID: 28345579
[TBL] [Abstract][Full Text] [Related]
14. Delta- and beta- secretases crosstalk amplifies the amyloidogenic pathway in Alzheimer's disease.
Xia Y; Wang ZH; Zhang Z; Liu X; Yu SP; Wang JZ; Wang XC; Ye K
Prog Neurobiol; 2021 Sep; 204():102113. PubMed ID: 34166772
[TBL] [Abstract][Full Text] [Related]
15. Nardilysin prevents amyloid plaque formation by enhancing α-secretase activity in an Alzheimer's disease mouse model.
Ohno M; Hiraoka Y; Lichtenthaler SF; Nishi K; Saijo S; Matsuoka T; Tomimoto H; Araki W; Takahashi R; Kita T; Kimura T; Nishi E
Neurobiol Aging; 2014 Jan; 35(1):213-22. PubMed ID: 23954170
[TBL] [Abstract][Full Text] [Related]
16. [Elucidating Pathogenic Mechanisms of Early-onset Alzheimer's Disease in Down Syndrome Patients].
Asai M; Kawakubo T; Mori R; Iwata N
Yakugaku Zasshi; 2017; 137(7):801-805. PubMed ID: 28674290
[TBL] [Abstract][Full Text] [Related]
17. Zileuton improves memory deficits, amyloid and tau pathology in a mouse model of Alzheimer's disease with plaques and tangles.
Chu J; Li JG; Praticò D
PLoS One; 2013; 8(8):e70991. PubMed ID: 23951061
[TBL] [Abstract][Full Text] [Related]
18. Targeting both BDNF/TrkB pathway and delta-secretase for treating Alzheimer's disease.
Liao J; Chen C; Ahn EH; Liu X; Li H; Edgington-Mitchell LE; Lu Z; Ming S; Ye K
Neuropharmacology; 2021 Oct; 197():108737. PubMed ID: 34343610
[TBL] [Abstract][Full Text] [Related]
19. Roles of glycogen synthase kinase 3 in Alzheimer's disease.
Cai Z; Zhao Y; Zhao B
Curr Alzheimer Res; 2012 Sep; 9(7):864-79. PubMed ID: 22272620
[TBL] [Abstract][Full Text] [Related]
20. PDK1 decreases TACE-mediated α-secretase activity and promotes disease progression in prion and Alzheimer's diseases.
Pietri M; Dakowski C; Hannaoui S; Alleaume-Butaux A; Hernandez-Rapp J; Ragagnin A; Mouillet-Richard S; Haik S; Bailly Y; Peyrin JM; Launay JM; Kellermann O; Schneider B
Nat Med; 2013 Sep; 19(9):1124-31. PubMed ID: 23955714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
